Who should permit monitoring and auditing by the sponsor, and inspections by regulatory authorities?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Who should permit monitoring and auditing by the sponsor, and inspections by regulatory authorities?

Explanation:
The investigator/institution is the party that permits these oversight activities. In ICH GCP, the site conducting the trial must allow the sponsor’s monitoring and audits and must grant access to trial records, source documents, facilities, and essential data. This access is essential to verify compliance with the protocol, GCP, and regulatory requirements and to protect participant rights and safety. The sponsor coordinates and conducts monitoring, and regulatory authorities may inspect, but they rely on the investigator/institution to provide access and cooperation. The IRB/IEC oversees ethical aspects and approval of the study, not the authorization for monitoring, audits, or inspections.

The investigator/institution is the party that permits these oversight activities. In ICH GCP, the site conducting the trial must allow the sponsor’s monitoring and audits and must grant access to trial records, source documents, facilities, and essential data. This access is essential to verify compliance with the protocol, GCP, and regulatory requirements and to protect participant rights and safety. The sponsor coordinates and conducts monitoring, and regulatory authorities may inspect, but they rely on the investigator/institution to provide access and cooperation. The IRB/IEC oversees ethical aspects and approval of the study, not the authorization for monitoring, audits, or inspections.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy